Medical Cannabis Aids In Easing Out Parkinsons Disease by Karishma Abhishek on February 2, 2021 at 6:12 AM Cannabis in Parkinson s Disease: The Patients View, Journal of Parkinson s Disease.
Parkinson s disease is a progressive neurodegenerative disorder that primarily affects movement due to loss of nerve cells - neurons that produce a chemical messenger (neurotransmitter) in the brain called dopamine (black substance). It is characterized by the formation of inclusion proteins called Lewy bodies. Medical cannabis was legally approved in Germany in 2017 when approval was given for therapy-resistant symptoms in severely affected patients independent of diagnosis and without clinical evidence-based data. PD patients fulfilling these criteria are entitled to be prescribed medical cannabis, but there are few data about which type of cannabinoid and which route of administration might be promising for which PD patient and which symptoms. We als
Over Half of Cannabis Users with Parkinson s Disease Report Clinical Benefits
A survey in Germany found more than eight percent of patients with Parkinson s disease are using cannabis products and more than half experienced beneficial clinical effects
January 28, 2021
AMSTERDAM, THE NETHERLANDS January 26, 2021 With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson s disease (PD). According to results of a survey of PD patients in Germany in the
, over eight of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect.
E-Mail
Amsterdam, NL, January 26, 2021 - With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson s disease (PD). According to results of a survey of PD patients in Germany in the
Journal of Parkinson s Disease, over 8% of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect.
Cannabis products containing THC (tetrahydrocannabinol, the main psychoactive compound of cannabis) can be prescribed in Germany when previous therapies are unsuccessful or not tolerated, and where cannabis can be expected with not a very unlikely chance to relieve disabling symptoms. CBD (pure cannabidiol, derived directly from the hemp plant, a cousin of the marijuana plant) is available without a prescription from pharmacies and on the internet.